Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New organ preservation solutions.

G M Collins1, W N Wicomb

  • 1California Pacific Medical Center, San Francisco.

Kidney International. Supplement
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a portable hypothermic microperfusion system for storage of the donor heart: clinical experience.

Transplantation proceedings·1998
Same author

Evaluation of unstored hearts: immediate functional differences between St Thomas, UW, and cardiosol following cardioplegia.

Transplantation proceedings·1998
Same author

What solutions are best? Overview of flush solutions.

Transplantation proceedings·1998
Same author

Liver transplantation from non-heart beating donors in rats: influence of viscosity and temperature of initial flushing solutions on graft function.

Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·1997
Same author

Treatment of hereditary ataxia with the levorotatory form of hydroxytryptophan.

Archives of neurology·1995
Same author

Twenty-four-hour ice storage of rabbit heart.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1994
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Optimizing hypothermic organ preservation solutions has advanced significantly since 1969. Research shows simplifying the University of Wisconsin (UW) solution and using organ-specific strategies improves preservation success.

Area of Science:

  • Transplantation
  • Organ Preservation
  • Surgical Innovation

Background:

  • The initial intracellular solution for kidney preservation in 1969 led to the development of the University of Wisconsin (UW) solution.
  • The UW solution became the accepted standard for hypothermic organ preservation.
  • Ongoing research aims to refine and improve upon existing preservation techniques.

Purpose of the Study:

  • To review advancements in hypothermic organ preservation solutions beyond the initial UW solution.
  • To explore modifications, organ-specific requirements, and novel additives for improved organ viability.
  • To assess the efficacy of new preservation strategies, including microperfusion and polyethylene glycol.

Main Methods:

  • Review of research on modifications and simplifications of the UW solution.

Related Experiment Videos

  • Investigation into organ-specific preservation requirements.
  • Evaluation of pharmacologic agents, microperfusion, and polyethylene glycol solutions.
  • Assessment of terminal rinse solutions to mitigate reperfusion injury.

    • Main Results:

    • Simplifying the UW solution by removing components can enhance preservation.
    • Organ-specific solutions are likely more effective than a universal approach.
    • Microperfusion and polyethylene glycol show promise, achieving near-perfect 24-hour heart preservation.
    • Terminal rinse solutions demonstrate potential for reducing reperfusion injury, pending clinical trials.

    Conclusions:

    • Hypothermic organ preservation has evolved, with potential for improvement over the standard UW solution.
    • Organ-specific preservation strategies and novel additives offer promising avenues for enhanced outcomes.
    • Further clinical evaluation is needed for promising techniques like terminal rinsing.